Hologic announces US FDA premarket approval for its ThinPrep Genesis cytology processor and specimen transfer system for downstream applications. The new instrument streamlines these workflows with advanced automation capabilities, including chain of custody verification, which prevents sample misidentification and increases results confidence. As the latest addition to Hologic’s suite of cytology instruments, the ThinPrep Genesis processor is designed to be a versatile and scalable solution for laboratories of all sizes. The instrument offers automation capabilities and workflow enhancements such as automated tube and slide labeling, bar code scanning, vial uncapping/capping, and sample aliquoting, which were developed to reduce hands-on time and repetitive motions, thereby improving ergonomics and streamlining lab performance.

• Hologic, Inc